HIV / AIDS in the News

Switch to Dovato Linked to Lower Rates of Steatotic Liver Disease Vs Biktarvy at 96 Weeks - Contagion Live

 

Budget Cuts Have Wide-Ranging Impact on PrEP Adherence at Home and Abroad - AJMC

 

What to know about HIV testing and treatment if you’re Black and LGBTQ+ - Advocate.com

 

A lab on wheels is tracking HIV spread in war-torn Ukraine - Science News

 

Long-Acting Injectable ART Preferences Emerge - European Medical Journal

 

ViiV Healthcare data show lower rates of steatotic liver disease after switching to Dovato - PharmaTimes

 

Management of Dyslipidemia in People Living With HIV: The REPRIEVE Paradigm in the 2025 ESC/EAS Guidelines Focused Update - American College of Cardiology

 

The war on science: resisting and rebuilding at a crucial juncture - Aidsmap

 

Assessing Targeted HIV and Harm Reduction Services - BIOENGINEER.ORG

 

Injectable ARVs In South Africa: A Comprehensive Guide - thedetroitbureau.com

 

Court awards Shs190m to man wrongly put on ARVs for seven years - Daily Monitor

 

PREGART 2 Project Officially Launched in Kampala to Advance Maternal and Pediatric HIV Research - Karolinska Institutet

 

This HIV Expert Refused To Censor Data, Then Quit the CDC - Out South Florida

 

Florida’s proposed cuts to AIDS drug program threaten patient care and public health - The Conversation

 

HIV patients show lower steatotic liver disease with ViiV’s Dovato vs Biktarvy - Clinical Trials Arena

 

NIH-supported trial reduces HIV incidence by 70% in rural populations - National Institutes of Health (.gov)

 

Maria Davis: Living Out Loud with HIV - amfAR, The Foundation for AIDS Research

 

New Strategies Aim at HIV’s Last Strongholds - WCM Newsroom

 

Millions Lost Access to PEPFAR-Supported HIV Drugs During the US Foreign Assistance Pause - Center for Global Development

 

Maternal HIV Alters Gut Microbiome, Metabolome in Pune - BIOENGINEER.ORG

 

Post-USAID, Kenyans’ Access To HIV And Maternal Medicine And Contraceptives Plunges - Health Policy Watch

 

Author Correction: NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology - Nature

 

Kazakhstan Accuses Two Suspects of Infecting Clients - VIDEO - Caspian Post

 

Minors living with HIV or human immunodeficiency virus can have access to antiretroviral (ARV) treatment through a proxy consent system, according to the Department of Health. https://tinyurl.com/54puvpj7 - facebook.com

 

POZ: Checkpoint inhibitors work well for HIV-positive people with cancer - European AIDS Treatment Group

 

[CROI 2026] AJMC: The 4 I’s: How HIV prevention, treatment can move forward in challenging times - European AIDS Treatment Group

 

Before You Ask for a Vote, Ask About the Policy That Failed Them - poz.com

 

[CROI 2026] AJMC: Tirzepatide improved weight, diabetes control in patients with HIV - European AIDS Treatment Group

 

[CROI 2026] [Press release] ViiV Healthcare announces data showing switching to Dovato was associated with a lower proportion of steatotic liver disease versus Biktarvy for HIV-1 treatment - European AIDS Treatment Group

 

[CROI 2026] Contagion Live: Switching to doravirine/islatravir maintains viral suppression through 96 weeks - European AIDS Treatment Group